November 8, 2016
Esperite's revenue slightly lifted in Q3 compared to same period last year
The Ducth pharmaceutical company Esperite N.V. has announced today that cumulative consolidated revenue increased
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
November 8, 2016
After $195 million in talc verdicts, J&J strives to change court
After a $67.5 million jury verdict against Johnson & Johnson…
November 8, 2016
DBV Technologies closes down phase II study of Viaskin Milk
DBV Technologies has completed the enrollment for Part B, or Phase II, of the Phase I/II study of Viaskin Milk
November 8, 2016
BRIEF: Advanced Oncotherpay appoints new broker
BRIEF: Advanced Oncotherpay appoints new broker
November 7, 2016
Testing investigational Zika vaccine candidate in humans
The first of five early stage clinical trials to test the safety and ability of an investigational Zika vaccine
November 7, 2016
Bayer seeks approval for its liver cancer drug
Bayer on Monday announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor
November 7, 2016
Vertex's Phase 3 cystic fibrosis drug study shows improvement
Vertex Pharmaceuticals Incorporated today announced the results of a Phase 3 study of Orkambi (lumacaftor/ivacaftor) in children with cystic fibrosis…
November 7, 2016
Orphan drugs make 35% Horizon's sale in Q3 2016
Horizon Pharma has announced its third-quarter 2016 financial results on Monday.
November 7, 2016
Neovacs enroles first U.S. patient in its Phase IIb study of IFNalpha Kinoid in lupus.
Neovacs, a player in active immunotherapy for the treatment of autoimmune diseases, has enroled the first U.S. patient in its international Phase IIb clinical study of IFNalpha Kinoid in lupus.
November 7, 2016
Amryt gets FDA's designation for orphan drug to treat acromegaly
Amryt has received orphan drug designation from U.S. Food and Drug Administration (FDA) for its drug compound…